Vitamin D-3 supplementation and neurofilament light chain in multiple sclerosis

Joost Smolders*, Max Mimpen, Johanna Oechtering, Jan Damoiseaux, Jody van den Ouweland, Raymond Hupperts, Jens Kuhle

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

16 Citations (Web of Science)
68 Downloads (Pure)

Abstract

Objectives Low circulating vitamin D levels are associated with an increased risk of active MRI lesions and relapses in several cohorts with relapsing remitting multiple sclerosis (RRMS). Randomized controlled supplementation trials are, however, negative on their primary endpoints, while secondary MRI endpoints suggest anti-inflammatory effects. Circulating levels of neurofilament light chain (NfL) are a biomarker of disease activity in RRMS. We explored whether 48-week high-dose vitamin D-3 supplements were associated with lower circulating NfL levels. Materials & Methods Of N = 40 Dutch interferon beta-treated participants with RRMS of the SOLAR trial, plasma samples at baseline and 48-week follow-up were available. Of these participants, N = 24 were supplemented with 14 000 IU/d vitamin D-3 and N = 16 with placebo. Twenty-five hydroxyvitamin D-3 (25(OH)D-3) levels were measured with LC-MS/MS, and NfL levels were measured in duplicate with Simoa. Results Serum 25(OH)D-3 levels at 48 weeks were increased in the vitamin D-3 when compared to placebo group (median level 281 [IQR 205-330] vs 72 [39-88] nmol/L; P <.01). NfL levels at 48 weeks did not differ between the treatment groups (median level 25.4 [IQR 19.6-32.2] vs 25.3 [17.9-30.1] pg/mL; P = .74). Higher week 48 NfL level showed a trend toward association with a higher risk of combined unique active lesions on the week 48 MRI scan (OR 2.39 [95% CI 0.93-6.12] for each 10 pg/mL increase; P = .07). Conclusions Supplementation of high-dose vitamin D-3 for 48 weeks was not associated with lower NfL levels. This study does not support an effect of vitamin D-3 on this biomarker of neuro-axonal injury.

Original languageEnglish
Pages (from-to)77-80
Number of pages4
JournalActa Neurologica Scandinavica
Volume141
Issue number1
Early online date2019
DOIs
Publication statusPublished - Jan 2020

Keywords

  • 25-hydroxyvitamin D
  • multiple sclerosis
  • neurofilament light chain
  • supplementation
  • vitamin D
  • EPSTEIN-BARR-VIRUS
  • DISEASE-ACTIVITY
  • TRIAL
  • BETA

Cite this